The objective of the proposed research is to develop several new classes of pre-clinical anti-HIV drugs (Phospholipid Anti-AIDS Drugs) that have phospholipid structures in common, but which may exhibit distinct therapeutic activities. Depending upon the class, PAD are designed to act: solely as biophysical agents (e.g., HIV envelope cholesterol-depleting); principally as chemotherapeutic agents/vesicles/formulations (e.g., phospholipid conjugates of drugs already established to be active to some degree in AIDS patients); or as biophysical-acting and chemotherapeutic agents. PAD, existing mostly as vesicles/micelles, would clearly exhibit different and most likely superior pharmacokinetics, as compared with certain presently known anti-AIDS, small-molecule experimental and clinical drugs. Methods of elaboration of PAD would include natural product chemistry, semi-synthesis, and total synthesis. Preparative high resolution chromatography (liquid) would be the principal means of separation and purification of PAD and natural- product and synthetic precursor intermediates. Biochemical studies would include: determination of the effect of PAD on lipid composition of HIV and host cell membranes; exploration of the relationship between viral envelop protein structure and membrane lipid; and mechanisms of virus-target cell binding and fusion. Physical techniques commonly used for studying the properties of phospholipid and biological membranes (scanning calorimetry, nuclear magnetic resonance, spectroscopic methods, light scattering, surface tension measurements, electron microscopy) will be used to characterize, singly, and in mixtures, the physical properties of the newly synthesized and formulated lipids. The effectiveness of fluidizing agents will be monitored by fluorescence polarization in lymphocyte membranes. These physical, formulation, and biochemical approaches will be used to aid the choice of appropriate lipids and mixtures, and to guide their formulation as stable agents. Those PAD showing promising activity against HIV infectivity in culture then would be considered for toxicologic studies in mice. At this level final decision on the preclinical and possibly clinical status of PADs will be made.

Project Start
1987-12-01
Project End
1990-11-30
Budget Start
1988-12-01
Budget End
1989-11-30
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Rhode Island
Department
Type
Schools of Pharmacy
DUNS #
135531015
City
Kingston
State
RI
Country
United States
Zip Code
02881
Patel, R A; Hutt-Fletcher, L M; Crews, F T (1993) Epstein-Barr virus infectivity of Raji and Molt 4 cells: differences in cellular membrane lipids and apparent microviscosity. Virology 195:121-31
Amari, J V; Brown, P R; Pivarnik, P E et al. (1992) Isolation of experimental anti-AIDS glycerophospholipids by micro-preparative reversed-phase high-performance liquid chromatography. J Chromatogr 590:153-61
Turcotte, J G; Lin, W H; Motola, N C et al. (1991) Chemical synthesis and surface activity of lung surfactant phospholipid analogs. III. Chiral N-substituted ether-amide phosphonolipids. Chem Phys Lipids 58:81-95
Amari, J V; Brown, P R; Pivarnik, P E et al. (1991) High-performance liquid chromatographic analysis of 3'-azido-3'-deoxythymidine monophosphate diglyceride, an anti-HIV glycerophospholipid. J Pharm Biomed Anal 9:871-5
Turcotte, J G; Lin, W H; Pivarnik, P E et al. (1991) Chemical synthesis and surface activity of lung surfactant phospholipid analogs. II. Racemic N-substituted diether phosphonolipids. Biochim Biophys Acta 1084:1-12
Steim, J M; Camaioni Neto, C; Sarin, P S et al. (1990) Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteins. Biochem Biophys Res Commun 171:451-7
Camaioni Neto, C; Steim, J M; Sarin, P S et al. (1990) Lipid conjugates of antiretroviral agents. II. Disodium palmityl phosphonoformate: anti-HIV activity, physical properties, and interaction with plasma proteins. Biochem Biophys Res Commun 171:458-64
Amari, J V; Brown, P R; Grill, C M et al. (1990) Isolation and purification of lecithin by preparative high-performance liquid chromatography. J Chromatogr 517:219-28
Turcotte, J G; Pivarnik, P E; Shirali, S S et al. (1990) Preparative-scale high-performance liquid chromatographic separation and purification of 3'-azido-3'-deoxythymidine-5'-phosphate. J Chromatogr 499:55-61
Haddad, R S; Hutt-Fletcher, L M (1989) Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. J Virol 63:4998-5005